Fortive Corporation Common Stock vs ImmunityBio Inc. Common Stock — how do they compare? Fortive Corporation Common Stock trades at $56.88 (market cap $17.04B), while ImmunityBio Inc. Common Stock trades at $10.37 (market cap $10.51B). The key difference: Fortive Corporation Common Stock is the larger of the two by market cap, and Fortive Corporation Common Stock pays a 0.5% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fortive Corporation Common Stock for 0 Days and ImmunityBio Inc. Common Stock for 0 Days on average.
| FTV | IBRX | |
|---|---|---|
Market Cap | $17.04B | $10.51B |
Volume | 2,190,596 | 10,445,785 |
Sector | Technology | Health |
52-Week High | $64.09 | $11.55 |
52-Week Low | $47.80 | $1.98 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $20.17B | $10.97B |
Dividend Yield | 0.5% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Fortive provides industrial and healthcare technology solutions. Its products and software support measurement, maintenance, worker safety, instrument sterilization, and clinical workflows.
Read more on FTV →ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →